SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Karolina Wartolowska, Morgan G. Hough, Mark Jenkinson, Jesper Andersson, B. Paul Wordsworth, Irene Tracey, Structural changes of the brain in rheumatoid arthritis, Arthritis & Rheumatism, 2012, 64, 2
  2. 2
    Elena P. Calandre, Fernando Rico-Villademoros, The Role of Antipsychotics in the Management of Fibromyalgia, CNS Drugs, 2012, 26, 2, 135

    CrossRef

  3. 3
    Neil S. Roskell, Stephen M. Beard, Yang Zhao, Trong Kim Le, A Meta-Analysis of Pain Response in the Treatment of Fibromyalgia, Pain Practice, 2011, 11, 6
  4. 4
    Ernest Choy, David Marshall, Zahava L. Gabriel, Stephen A. Mitchell, Elizabeth Gylee, Helen A. Dakin, A Systematic Review and Mixed Treatment Comparison of the Efficacy of Pharmacological Treatments for Fibromyalgia, Seminars in Arthritis and Rheumatism, 2011, 41, 3, 335

    CrossRef

  5. 5
    P. Cherin, Actualités dans la fibromyalgie, Médecine & Longévité, 2011, 3, 1, 3

    CrossRef

  6. 6
    Eric S Hsu, Acute and Chronic Pain Management in Fibromyalgia: Updates on Pharmacotherapy, American Journal of Therapeutics, 2011, 18, 6, 487

    CrossRef

  7. 7
    Matthias F Seidel, Wolfgang Müller, Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists, Expert Opinion on Pharmacotherapy, 2011, 12, 9, 1381

    CrossRef

  8. 8
    Tobias Schmidt-Wilcke, Daniel J. Clauw, Fibromyalgia: from pathophysiology to therapy, Nature Reviews Rheumatology, 2011, 7, 9, 518

    CrossRef

  9. 9
    Pierre A. Geoffroy, Ali Amad, Christine Gangloff, Pierre Thomas, Fibromyalgie et psychiatrie : 35 ans plus tard… Quoi de neuf ?, La Presse Médicale, 2011,

    CrossRef

  10. 10
    F. Reyero, G. Ponce, R. Rodriguez-Jimenez, P. Fernandez-Dapica, D. Taboada, V. Martin, M. Navio, M.A. Jimenez-Arriero, J. Hoenicka, T. Palomo, High frequency of childhood ADHD history in women with fibromyalgia, European Psychiatry, 2011, 26, 8, 482

    CrossRef

  11. 11
    Kanwaljit Chopra, Anurag Kuhad, Vipin Arora, Neoteric pharmacotherapeutic targets in fibromyalgia, Expert Opinion on Therapeutic Targets, 2011, 15, 11, 1267

    CrossRef

  12. 12
    D. Borsook, Neurological diseases and pain, Brain, 2011, 135, 2, 320

    CrossRef

  13. 13
    Don L. Goldenberg, Daniel J. Clauw, Mary-Ann Fitzcharles, New Concepts in Pain Research and Pain Management of the Rheumatic Diseases, Seminars in Arthritis and Rheumatism, 2011, 41, 3, 319

    CrossRef

  14. 14
    Philip J. Mease, Kelly Dundon, Piercarlo Sarzi-Puttini, Pharmacotherapy of fibromyalgia, Best Practice & Research Clinical Rheumatology, 2011, 25, 2, 285

    CrossRef

  15. 15
    Akihiko Morita, Yasuyuki Okuma, Satoshi Kamei, Fumihito Yoshii, Toshimasa Yamamoto, Shiori Hashimoto, Hiroya Utsumi, Taku Hatano, Nobutaka Hattori, Miyuki Matsumura, Kazushi Takahashi, Shigeru Nogawa, Yuka Watanabe, Tomoyuki Miyamoto, Masayuki Miyamoto, Koichi Hirata, Pramipexole Reduces the Prevalence of Fatigue in Patients with Parkinson's Disease, Internal Medicine, 2011, 50, 19, 2163

    CrossRef

  16. 16
    Sang-Hyon Kim, Sung-Won Jung, Psychiatric Approach of Fibromyalgia, Journal of Rheumatic Diseases, 2011, 18, 4, 242

    CrossRef

  17. 17
    Suely Roizenblatt, Nilton Salles Rosa Neto, Sergio Tufik, Sleep Disorders and Fibromyalgia, Current Pain and Headache Reports, 2011, 15, 5, 347

    CrossRef

  18. 18
    Kate Louise Franklyn, Emma Kathryn Guymer, Geoffrey Owen Littlejohn, Targeting fibromyalgia pain: brain–spinal cord and peripheral contributions, International Journal of Clinical Rheumatology, 2011, 6, 4, 463

    CrossRef

  19. 19
    Gene-Siew NGIAN, Emma K. GUYMER, Geoffrey O. LITTLEJOHN, The use of opioids in fibromyalgia, International Journal of Rheumatic Diseases, 2011, 14, 1
  20. 20
    Javier Rivera Redondo, Tratamiento farmacológico en la fibromialgia, Seminarios de la Fundación Española de Reumatología, 2011, 12, 1, 21

    CrossRef

  21. 21
    Howard S. Smith, Richard E. Harris, Daniel J. Clauw, Essentials of Pain Medicine, 2011,

    CrossRef

  22. 22
    Oliver Distler, Wolfgang Eich, Eva Dokoupilova, Zdenek Dvorak, Martin Fleck, Markus Gaubitz, Manfred Hechler, Jan-Peter Jansen, Andreas Krause, Martin Bendszus, Lothar Pache, Rudolf Reiter, Ulf Müller-Ladner, Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: Results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study, Arthritis & Rheumatism, 2010, 62, 1
  23. 23
    Roland Staud, Pharmacological Treatment of Fibromyalgia Syndrome, Drugs, 2010, 70, 1, 1

    CrossRef

  24. 24
    Eduardo S. Paiva, Kim Dupree Jones, Rational treatment of fibromyalgia for a solo practitioner, Best Practice & Research Clinical Rheumatology, 2010, 24, 3, 341

    CrossRef

  25. 25
    T. Schmidt-Wilcke, P. Wood, R. Lürding, Schmerz und Aufmerksamkeit, Der Schmerz, 2010, 24, 1, 46

    CrossRef

  26. 26
    Rodrigo CL Edelmuth, Michael A Nitsche, Linamara Battistella, Felipe Fregni, Why do some promising brain-stimulation devices fail the next steps of clinical development?, Expert Review of Medical Devices, 2010, 7, 1, 67

    CrossRef

  27. 27
    Chad S. Boomershine, Leslie J. Crofford, A symptom-based approach to pharmacologic management of fibromyalgia, Nature Reviews Rheumatology, 2009, 5, 4, 191

    CrossRef

  28. 28
    Laura Bazzichi, Lionella Palego, Gino Giannaccini, Alessandra Rossi, Francesca De Feo, Camillo Giacomelli, Laura Betti, Laura Giusti, Giovanni Mascia, Stefano Bombardieri, Antonio Lucacchini, Altered amino acid homeostasis in subjects affected by fibromyalgia, Clinical Biochemistry, 2009, 42, 10-11, 1064

    CrossRef

  29. 29
    Andrew J Holman, Assessing patients with fibromyalgia from a rheumatologist’s perspective: a three-step methodology for differential diagnosis, International Journal of Clinical Rheumatology, 2009, 4, 4, 409

    CrossRef

  30. 30
    Roi Treister, Dorit Pud, Richard P. Ebstein, Efrat Laiba, Edith Gershon, May Haddad, Elon Eisenberg, Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans, PAIN, 2009, 147, 1-3, 187

    CrossRef

  31. 31
    Yukinori Nagakura, Tomoya Oe, Toshiaki Aoki, Nobuya Matsuoka, Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia, PAIN, 2009, 146, 1-2, 26

    CrossRef

  32. 32
    Seong-Ho Kim, Fibromyalgia Syndrome, The Journal of the Korean Rheumatism Association, 2009, 16, 1, 1

    CrossRef

  33. 33
    Stephen M. Stahl, Fibromyalgia—pathways and neurotransmitters, Human Psychopharmacology: Clinical and Experimental, 2009, 24, S1
  34. 34
    Michael Spaeth, Mike Briley, Fibromyalgia: a complex syndrome requiring a multidisciplinary approach, Human Psychopharmacology: Clinical and Experimental, 2009, 24, S1
  35. 35
    Emma Guymer, Geoffrey Littlejohn, Fibromyalgia: current diagnosis and management, Expert Review of Clinical Immunology, 2009, 5, 2, 181

    CrossRef

  36. 36
    Dawn A. Marcus, Fibromyalgia: Diagnosis and treatment options, Gender Medicine, 2009, 6, 139

    CrossRef

  37. 37
    Stéphane Potvin, Sylvain Grignon, Serge Marchand, Human evidence of a supra-spinal modulating role of dopamine on pain perception, Synapse, 2009, 63, 5
  38. 38
    Andrew J. Holman, Impulse Control Disorder Behaviors Associated with Pramipexole Used to Treat Fibromyalgia, Journal of Gambling Studies, 2009, 25, 3, 425

    CrossRef

  39. 39
    Ather Ali, Valentine Yanchou Njike, Veronika Northrup, Alyse B. Sabina, Anna-Leila Williams, Lauren S. Liberti, Adam I. Perlman, Harry Adelson, David L. Katz, Intravenous Micronutrient Therapy (Myers' Cocktail) for Fibromyalgia: A Placebo-Controlled Pilot Study, The Journal of Alternative and Complementary Medicine, 2009, 15, 3, 247

    CrossRef

  40. 40
    Philip J. Mease, Ernest H. Choy, Pharmacotherapy of Fibromyalgia, Rheumatic Disease Clinics of North America, 2009, 35, 2, 359

    CrossRef

  41. 41
    Andrew J. Holman, Pregabalin as treatment for fibromyalgia: The rest of the story?, Current Pain and Headache Reports, 2009, 13, 6, 420

    CrossRef

  42. 42
    Harvey Moldofsky, The Significance of Dysfunctions of the Sleeping/Waking Brain to the Pathogenesis and Treatment of Fibromyalgia Syndrome, Rheumatic Disease Clinics of North America, 2009, 35, 2, 275

    CrossRef

  43. 43
    David A. Williams, Daniel J. Clauw, Understanding Fibromyalgia: Lessons from the Broader Pain Research Community, The Journal of Pain, 2009, 10, 8, 777

    CrossRef

  44. 44
    Thomas L. Schwartz, Adam C. Tripp, Depression, 2009,

    CrossRef

  45. 45
    Muhammad B. Yunus, Central Sensitivity Syndromes: A New Paradigm and Group Nosology for Fibromyalgia and Overlapping Conditions, and the Related Issue of Disease versus Illness, Seminars in Arthritis and Rheumatism, 2008, 37, 6, 339

    CrossRef

  46. 46
    S. Potvin, S. Grignon, Dopamine et douleur : une revue de littérature, Douleur et Analgésie, 2008, 20, 4, 246

    CrossRef

  47. 47
    I. Jon Russell, Philip J. Mease, Timothy R. Smith, Daniel K. Kajdasz, Madelaine M. Wohlreich, Michael J. Detke, Daniel J. Walker, Amy S. Chappell, Lesley M. Arnold, Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial, PAIN, 2008, 136, 3, 432

    CrossRef

  48. 48
    Jacob N Ablin, Dan Buskila, Emerging therapies for fibromyalgia, Expert Opinion on Emerging Drugs, 2008, 13, 1, 53

    CrossRef

  49. 49
    A. Rahman, E. Reed, M. Underwood, M. E. Shipley, R. Z. Omar, Factors affecting self-efficacy and pain intensity in patients with chronic musculoskeletal pain seen in a specialist rheumatology pain clinic, Rheumatology, 2008, 47, 12, 1803

    CrossRef

  50. 50
    Dennis C. Turk, Charles J. Vierck, Elizabeth Scarbrough, Leslie J. Crofford, Nathan J. Rudin, Fibromyalgia: Combining Pharmacological and Nonpharmacological Approaches to Treating the Person, Not Just the Pain, The Journal of Pain, 2008, 9, 2, 99

    CrossRef

  51. 51
    Stefano Coaccioli, Giustino Varrassi, Chiara Sabatini, Franco Marinangeli, Marco Giuliani, Adolfo Puxeddu, Fibromyalgia: Nosography and Therapeutic Perspectives, Pain Practice, 2008, 8, 3
  52. 52
    Philip J. Mease, Kristin Seymour, Fibromyalgia: Should the treatment paradigm be monotherapy or combination pharmacotherapy?, Current Pain and Headache Reports, 2008, 12, 6, 399

    CrossRef

  53. 53
    Y. Dauvilliers, B. Carlander, Fibromyalgie : exemple d’interactions entre sommeil et douleur, Douleur et Analgésie, 2008, 20, 4, 239

    CrossRef

  54. 54
    P. Arsenault, S. Potvin, Interventions pharmacologiques chez le patient fibromyalgique : par où commencer ?, Douleur et Analgésie, 2008, 20, 4, 227

    CrossRef

  55. 55
    L. Auquier, D. Bontoux, H. Löo, P. Godeau, C.-J. Menkès, J.-B. Paolaggi, S. Perrot, La fibromyalgie, La Revue de Médecine Interne, 2008, 29, 2, 161

    CrossRef

  56. 56
    C. Sommer, W. Häuser, M. Berliner, W. Brückle, S. Ehlers, K. Mönkemöller, B. Moradi, F. Petzke, N. Üçeyler, R. Wörz, E. Winter, D.O. Nutzinger, Medikamentöse Therapie des Fibromyalgiesyndroms, Der Schmerz, 2008, 22, 3, 313

    CrossRef

  57. 57
    Ryan Quinlan Skrabek, Lena Galimova, Karen Ethans, Daryl Perry, Nabilone for the Treatment of Pain in Fibromyalgia, The Journal of Pain, 2008, 9, 2, 164

    CrossRef

  58. 58
    Jacob Ablin, Lily Neumann, Dan Buskila, Pathogenesis of fibromyalgia – A review, Joint Bone Spine, 2008, 75, 3, 273

    CrossRef

  59. 59
    Kim Lawson, Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies?, Drug Discovery Today, 2008, 13, 7-8, 333

    CrossRef

  60. 60
    Andrew J. Holman, Positional Cervical Spinal Cord Compression and Fibromyalgia: A Novel Comorbidity With Important Diagnostic and Treatment Implications, The Journal of Pain, 2008, 9, 7, 613

    CrossRef

  61. 61
    Andrew J. Holman, Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia, Current Pain and Headache Reports, 2008, 12, 6, 393

    CrossRef

  62. 62
    Heinz Reichmann, Werner Martin Michael Schüpbach, Pramipexole in the management of Parkinson’s disease, Aging Health, 2008, 4, 3, 225

    CrossRef

  63. 63
    Patrick B Wood, Role of central dopamine in pain and analgesia, Expert Review of Neurotherapeutics, 2008, 8, 5, 781

    CrossRef

  64. 64
    Harvey Moldofsky, The significance of the sleeping–waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes, Joint Bone Spine, 2008, 75, 4, 397

    CrossRef

  65. 65
    Piercarlo Sarzi-Puttini, Dan Buskila, Mario Carrabba, Andrea Doria, Fabiola Atzeni, Treatment Strategy in Fibromyalgia Syndrome: Where Are We Now?, Seminars in Arthritis and Rheumatism, 2008, 37, 6, 353

    CrossRef

  66. 66
    R. Luerding, T. Weigand, U. Bogdahn, T. Schmidt-Wilcke, Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition interaction, Brain, 2008, 131, 12, 3222

    CrossRef

  67. 67
    Kim Lawson, Are complex therapies required as pharmacological treatments of fibromyalgia?, Future Rheumatology, 2007, 2, 6, 599

    CrossRef

  68. 68
    Muhammad B. Yunus, Fibromyalgia and Overlapping Disorders: The Unifying Concept of Central Sensitivity Syndromes, Seminars in Arthritis and Rheumatism, 2007, 36, 6, 339

    CrossRef

  69. 69
    Daniel S Rooks, Fibromyalgia treatment update, Current Opinion in Internal Medicine, 2007, 6, 3, 328

    CrossRef

  70. 70
    Robert R Ferrari, Anthony S Russell, Fibromyalgia: 30 years of drug-seeking behavior, Nature Clinical Practice Rheumatology, 2007, 3, 2, 62

    CrossRef

  71. 71
    Daniel J. Clauw, Fibromyalgia: Update on Mechanisms and Management, JCR: Journal of Clinical Rheumatology, 2007, 13, 2, 102

    CrossRef

  72. 72
    P. Harten, Fibromyalgiesyndrom, Zeitschrift für Rheumatologie, 2007, 67, 1, 75

    CrossRef

  73. 73
    Patrick B Wood, Andrew J Holman, Kim D Jones, Novel pharmacotherapy for fibromyalgia, Expert Opinion on Investigational Drugs, 2007, 16, 6, 829

    CrossRef

  74. 74
    Katsuhiro Toda, Toshihide Harada, Fumiko Ishizaki, Nobuko Horie, Tohru Yamada, Parkinson disease patient with fibromyalgia: A case report, Parkinsonism & Related Disorders, 2007, 13, 5, 312

    CrossRef

  75. 75
    Don L. Goldenberg, Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain, Best Practice & Research Clinical Rheumatology, 2007, 21, 3, 499

    CrossRef

  76. 76
    Hans-Peter Kapfhammer, Psychopharmakotherapie somatoformer Störungen und funktioneller somatischer Syndrome, Psychiatrie und Psychotherapie, 2007, 3, 4, 153

    CrossRef

  77. 77
    Patrick B. Wood, James C. Patterson, John J. Sunderland, Kerrie H. Tainter, Michael F. Glabus, David L. Lilien, Reduced Presynaptic Dopamine Activity in Fibromyalgia Syndrome Demonstrated With Positron Emission Tomography: A Pilot Study, The Journal of Pain, 2007, 8, 1, 51

    CrossRef

  78. 78
    T. Schmidt-Wilcke, R. Luerding, T. Weigand, T. Jürgens, G. Schuierer, E. Leinisch, U. Bogdahn, Striatal grey matter increase in patients suffering from fibromyalgia – A voxel-based morphometry study, PAIN, 2007, 132, S109

    CrossRef

  79. 79
    Brian Walitt, Tresa Roebuck-Spencer, Guiseppe Esposito, Frances Atkins, Joseph Bleiberg, Gregory Foster, Arthur Weinstein, The effects of multidisciplinary therapy on positron emission tomography of the brain in fibromyalgia: a pilot study, Rheumatology International, 2007, 27, 11, 1019

    CrossRef

  80. 80
    Roland Staud, Treatment of fibromyalgia and its symptoms, Expert Opinion on Pharmacotherapy, 2007, 8, 11, 1629

    CrossRef

  81. 81
    Patrick B. Wood, A Reconsideration of the Relevance of Systemic Low-Dose Ketamine to the Pathophysiology of Fibromyalgia, The Journal of Pain, 2006, 7, 9, 611

    CrossRef

  82. 82
    Jacob N Ablin, Hagit Cohen, Dan Buskila, Mechanisms of Disease: genetics of fibromyalgia, Nature Clinical Practice Rheumatology, 2006, 2, 12, 671

    CrossRef

  83. 83
    José L. Callejas-Rubio, Lourdes López-Pérez, Francisco Navarro-Pelayo, Norberto Ortego-Centeno, Otras opciones terapéuticas en la fibromialgia, Medicina Clínica, 2006, 127, 2, 76

    CrossRef

  84. 84
    Dina Dadabhoy, Daniel J Clauw, Therapy Insight: fibromyalgia—a different type of pain needing a different type of treatment, Nature Clinical Practice Rheumatology, 2006, 2, 7, 364

    CrossRef

  85. 85
    Dina Dadabhoy, Daniel J. Clauw, Fibromyalgia: Progress in diagnosis and treatment, Current Pain and Headache Reports, 2005, 9, 6, 399

    CrossRef

  86. 86
    Andrew J Holman, Treatment of fibromyalgia: a changing of the guard, Women's Health, 2005, 1, 3, 409

    CrossRef

  87. 87
    Shen-Yang Lim, Andrew H. Evans, Pain and Paresthesia in Parkinson's Disease,